Actionable news
0
All posts from Actionable news
Actionable news in IONS: IONIS PHARMACEUTICALS Inc COMMON STOCK,

Jim Cramer — Celgene Igniting a Rally in Biotech

Earlier Monday, TheStreet's Jim Cramer discussed Ionis Pharmaceutical (IONS) and Biogen (BIIB) following Ionis' successful late-stage clinical trial for one of its treatments.

He continued the biotech theme on CNBC's "Stop Trading" segment, focusing on Celgene (CELG) , up 1.6%. The company's stock has been rising since last Thursday when it beat on revenue and earnings.

JUST...


More